Online citations, reference lists, and bibliographies.
← Back to Search

Paclitaxel Sensitivity Of Breast Cancer Cells With Constitutively Active NF-κB Is Enhanced By IκBα Super-repressor And Parthenolide

N. Patel, S. Nozaki, N. H. Shortle, P. Bhat-Nakshatri, T. R. Newton, S. Rice, V. Gelfanov, S. Boswell, R. Goulet, G. Sledge, H. Nakshatri
Published 2000 · Biology

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
The transcription factor nuclear factor-κB (NF-κB) regulates genes important for tumor invasion, metastasis and chemoresistance. Normally, NF-κB remains sequestered in an inactive state by cytoplasmic inhibitor-of-κB (IκB) proteins. NF-κB translocates to nucleus and activates gene expression upon exposure of cells to growth factors and cytokines. We and others have shown previously that NF-κB is constitutively active in a subset of breast cancers. In this study, we show that constitutive activation of NF-κB leads to overexpression of the anti-apoptotic genes c-inhibitor of apoptosis 2 (c-IAP2) and manganese superoxide dismutase (Mn-SOD) in breast cancer cells. Furthermore, expression of the anti-apoptotic tumor necrosis factor receptor associated factor 1 (TRAF1) and defender-against cell death (DAD-1) is regulated by NF-κB in certain breast cancer cells. We also demonstrate that NF-κB-inducible genes protect cancer cells against paclitaxel as MDA-MB-231 breast cancer cells modified to overexpress IκBα required lower concentrations of paclitaxel to arrest at the G2/M phase of the cell cycle and undergo apoptosis when compared to parental cells. The effect of NF-κB on paclitaxel-sensitivity appears to be specific to cancer cells because normal fibroblasts derived from embryos lacking p65 subunit of NF-κB and wild type littermate embryos were insensitive to paclitaxel-induced G2/M cell cycle arrest. Parthenolide, an active ingredient of herbal remedies such as feverfew (tanacetum parthenium), mimicked the effects of IκBα by inhibiting NF-κB DNA binding activity and Mn-SOD expression, and increasing paclitaxel-induced apoptosis of breast cancer cells. These results suggest that active ingredients of herbs with anti-inflammatory properties may be useful in increasing the sensitivity of cancers with constitutively active NF-κB to chemotherapeutic drugs.
This paper references
10.1177/001452469000101110
"J."
G. G. Stokes (1890)
10.1016/S0065-230X(08)60912-4
Criteria for analyzing interactions between biologically active agents.
M. Berenbaum (1981)
10.1093/NAR/11.5.1475
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.
J. Dignam (1983)
10.1016/S0140-6736(88)92289-1
RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FEVERFEW IN MIGRAINE PREVENTION
J. Murphy (1988)
Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice.
J. Price (1990)
10.1002/j.1460-2075.1990.tb07394.x
The collagenase gene promoter contains a TPA and oncogene‐responsive unit encompassing the PEA3 and AP‐1 binding sites.
A. Gutman (1990)
10.1016/0092-8674(91)90642-C
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
L. Liotta (1991)
10.1016/0092-8674(94)90518-5
Apoptosis in cancer therapy: Crossing the threshold
D. Fisher (1994)
10.1146/ANNUREV.IY.12.040194.001041
Function and activation of NF-kappa B in the immune system.
P. Baeuerle (1994)
Breast Cancer Res
CL Sommers (1994)
Taxol induction of p21WAF1 and p53 requires c-raf-1.
M. V. Blagosklonny (1995)
10.1126/science.274.5288.782
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
A. Beg (1996)
10.1073/PNAS.93.25.14559
BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases.
J. Xiang (1996)
10.1126/science.274.5288.784
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Cun-Yu Wang (1996)
Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway.
M. V. Blagosklonny (1996)
Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells.
R. Kumar (1996)
10.1172/JCI118715
Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice.
R. Bargou (1996)
Clin
R Kumar (1996)
Proc
J Xiang (1996)
10.1074/jbc.272.34.21096
Novel Inhibitors of Cytokine-induced IκBα Phosphorylation and Endothelial Cell Adhesion Molecule Expression Show Anti-inflammatory Effects in Vivo*
J. Pierce (1997)
10.1074/JBC.272.23.14914
Activation of NF-kappaB by antineoplastic agents. Role of protein kinase C.
K. Das (1997)
10.1128/MCB.17.12.6970
Tumor necrosis factor alpha and interleukin-1beta regulate the murine manganese superoxide dismutase gene through a complex intronic enhancer involving C/EBP-beta and NF-kappaB.
P. L. Jones (1997)
Enhanced Degradation of I-κBα Contributes to Endogenous Activation of NF-κB in Hs294T Melanoma Cells
R. Shattuck-Brandt (1997)
10.1038/NM0497-378
Multidrug resistance — a multiplex phenomenon
N. Baldini (1997)
10.1073/PNAS.94.10.4994
DAD1, the defender against apoptotic cell death, is a subunit of the mammalian oligosaccharyltransferase.
D. Kelleher (1997)
10.1172/JCI119848
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
M. Sovak (1997)
10.1128/MCB.17.7.3629
Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth.
H. Nakshatri (1997)
10.1172/JCI119849
Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.
R. Bargou (1997)
10.1093/NAR/25.12.2424
Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site.
R. Galien (1997)
10.1016/S0014-5793(96)01502-5
Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF‐κB
P. Bork (1997)
10.1038/bjc.1997.156
Synergistic antiproliferative activity of tamoxifen and docetaxel on three oestrogen receptor-negative cancer cell lines is mediated by the induction of apoptosis.
C. Ferlini (1997)
Mol
H Nakshatri (1997)
Mol
PL Jones (1997)
Histol
TD Oberley (1997)
Proc
DJ Kelleher (1997)
10.1101/GAD.12.7.968
A requirement for NF-κB activation in Bcr–Abl-mediated transformation
J. Y. Reuther (1998)
10.1038/25141
Control of apoptosis and mitotic spindle checkpoint by survivin
F. Li (1998)
10.1055/S-2006-957558
Cistifolin, an integrin-dependent cell adhesion blocker from the anti-rheumatic herbal drug, gravel root (rhizome of Eupatorium purpureum).
S. Habtemariam (1998)
10.1074/JBC.273.22.14008
Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates.
D. Giri (1998)
10.1073/PNAS.95.12.6971
NF-κB activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1α
P. Bhat-Nakshatri (1998)
10.1093/JN/128.12.2334
Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model.
F. Yang (1998)
10.1084/JEM.187.4.579
Caspase-mediated Cleavage of Focal Adhesion Kinase pp125FAK and Disassembly of Focal Adhesions in Human Endothelial Cell Apoptosis
B. Levkau (1998)
10.1126/SCIENCE.281.5381.1309
Mitochondria and apoptosis.
D. Green (1998)
10.1074/jbc.273.21.13245
Overexpression of Manganese Superoxide Dismutase Suppresses Tumor Necrosis Factor-induced Apoptosis and Activation of Nuclear Transcription Factor-κB and Activated Protein-1*
Sunil K. Manna (1998)
10.1126/SCIENCE.281.5383.1680
NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.
C. Wang (1998)
10.1002/(SICI)1096-9896(199808)185:4<382::AID-PATH124>3.0.CO;2-4
Comparative genomic hybridization reveals frequent chromosome 13q and 4q losses in renal carcinomas with sarcomatoid transformation
F. Jiang (1998)
10.1074/jbc.273.30.18984
Phosphorylation of Bcl-2 Is a Marker of M Phase Events and Not a Determinant of Apoptosis*
Y. Ling (1998)
10.1111/J.1752-7325.1998.TB03000.X
Coverage and quality of oral cancer information in the popular press: 1987-98.
M. Canto (1998)
10.1038/23948
The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
M. Yin (1998)
10.1182/BLOOD.V91.12.4480.412K28_4480_4488
Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients
O. Legrand (1998)
Paclitaxel-associated multimininucleation is permitted by the inhibition of caspase activation: a potential early step in drug resistance.
R. Panvichian (1998)
10.1074/JBC.273.50.33508
The Anti-inflammatory Sesquiterpene Lactone Helenalin Inhibits the Transcription Factor NF-κB by Directly Targeting p65*
Guido Lyß (1998)
10.1126/SCIENCE.281.5381.1312
Caspases: enemies within.
N. Thornberry (1998)
10.1016/S0006-2952(97)00557-1
Curcumin (Diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation.
A. Kumar (1998)
Proc
H. (1998)
Biochem
A Kumar (1998)
Stable inhibition of nuclear factor kappaB in cancer cells does not increase sensitivity to cytotoxic drugs.
M. Bentires-Alj (1999)
10.1073/PNAS.96.16.9136
NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes.
H. H. Lee (1999)
10.1055/S-2006-960795
Inhibition of activator protein 1 activity by berberine in human hepatoma cells.
K. Fukuda (1999)
10.1074/jbc.274.26.18827
Negative Regulation of Transactivation Function but Not DNA Binding of NF-κB and AP-1 by IκBβ1 in Breast Cancer Cells*
T. R. Newton (1999)
10.1101/GAD.13.4.400
Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis.
R. Grumont (1999)
10.1128/MCB.19.4.2690
NF-κB Function in Growth Control: Regulation of Cyclin D1 Expression and G0/G1-to-S-Phase Transition
M. Hinz (1999)
10.1101/GAD.13.4.382
The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis
Wei-Xing Zong (1999)
10.1128/MCB.19.8.5785
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
D. Guttridge (1999)
The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma.
G. Dong (1999)
10.1128/MCB.19.7.4547
Bridging the Gap: Composition, Regulation, and Physiological Function of the IκB Kinase Complex
Ebrahim Zandi (1999)
10.1038/12050
Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-κB loop
B. Levkau (1999)
10.1016/S0955-0674(99)80017-9
Accessory protein regulation of microtubule dynamics throughout the cell cycle.
L. Cassimeris (1999)
10.1038/7410
Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB
C. Wang (1999)
10.1101/GAD.13.3.239
IAP family proteins--suppressors of apoptosis.
Q. Deveraux (1999)
10.1128/MCB.19.9.5923
NF-κB Induces Expression of the Bcl-2 Homologue A1/Bfl-1 To Preferentially Suppress Chemotherapy-Induced Apoptosis
Cun-Yu Wang (1999)
Nat
CY Wang (1999)
Mol
E Zandi (1999)
Mol
DC Guttridge (1999)
Nature Cell
B Levkau (1999)
Mol
CY Wang (1999)
Proc
HH Lee (1999)
Mol
M Hinz (1999)
Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer.
H. Miyake (2000)
10.1038/sj.onc.1203412
Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3
P. Cogswell (2000)
Oncogene, 19, 1123 ± 1131
Jr AS. (2000)



This paper is referenced by
10.33448/RSD-V10I4.14098
Drug combination and nanooncology for improvement in the treatment of breast cancer: a review
R. Faria (2021)
10.1093/noajnl/vdab006
Phase I dose-escalation, safety, and CNS pharmacokinetic study of dexanabinol in patients with brain cancer
Tiffany Juarez (2021)
10.4018/978-1-7998-6530-8.ch022
Functional Mechanisms of Green Tea Polyphenols and Their Molecular Targets in Prevention of Multiple Cancers
Z. Hafeez (2021)
10.1016/j.drup.2021.100754
Therapeutic strategies to overcome taxane resistance in cancer.
Tuyelee Das (2021)
10.1016/j.ijpharm.2020.119375
Preparation and characterization of parthenolide nanocrystals for enhancing therapeutic effects of sorafenib against advanced hepatocellular carcinoma.
P. Liang (2020)
10.1016/j.bmc.2020.115557
Synthesis, cytotoxicity, and in vivo antitumor activity study of parthenolide semicarbazones and thiosemicarbazones.
Xinxin Jia (2020)
10.3390/molecules25071479
A New Hybrid δ-Lactone Induces Apoptosis and Potentiates Anticancer Activity of Taxol in HL-60 Human Leukemia Cells
Katarzyna Gach-Janczak (2020)
10.1177/2472555220922817
A High-Throughput Image Cytometry Method for the Formation, Morphometric, and Viability Analysis of Drug-Treated Mammospheres
S. Kessel (2020)
10.3390/ph13080194
Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies
M. Sztiller-Sikorska (2020)
10.1177/1533033820945821
Paclitaxel Promotes Tumor-Infiltrating Macrophages in Breast Cancer
Jun Shen (2020)
10.34172/PS.2020.32
Effects of Hydro-ethanolic Extract of Tanacetum parthenium and its N-Butanol and Aqueous Fractions on Brain Oxidative Damage in Pentylenetetrazole-Induced Seizures in Mice
Fereshteh Asgharzadeh (2020)
10.1016/j.bbcan.2020.188450
HOX genes and the NF-κB pathway: A convergence of developmental biology, inflammation and cancer biology.
P. Pai (2020)
10.1007/978-3-030-20301-6_8
Therapeutic Options for Metastatic Breast Cancer.
Manpreet Sambi (2019)
10.17533/UDEA.VITAE.V26N1A04
Therapeutic potential of omega fatty acids in breast cancer. Review
M. Márquez-Fernández (2019)
10.1007/978-981-32-9147-8_4
Plants with Anticancer Potential
B. Koul (2019)
10.1021/ACSOMEGA.9B00020
Large-Scale Target Identification of Herbal Medicine Using a Reverse Docking Approach
H. Zhang (2019)
10.1155/2019/1982570
STAT3 Activation in Combination with NF-KappaB Inhibition Induces Tolerogenic Dendritic Cells with High Therapeutic Potential to Attenuate Collagen-Induced Arthritis
Carolina E. Prado (2019)
STAT 3 Activation in Combination with NF-KappaB Inhibition Induces Tolerogenic Dendritic Cells with High Therapeutic Potential to Attenuate Collagen-Induced Arthritis
Carolina E. Prado (2019)
10.12659/MSM.915387
Parthenolide Inhibits the Proliferation of MDA-T32 Papillary Thyroid Carcinoma Cells in Vitro and in Mouse Tumor Xenografts and Activates Autophagy and Apoptosis by Downregulation of the Mammalian Target of Rapamycin (mTOR)/PI3K/AKT Signaling Pathway
C. Li (2019)
10.1016/B978-0-12-812373-7.00001-2
Pathways Linked to Cancer Chemoresistance and Their Targeting by Nutraceuticals
A. Bharti (2018)
10.1007/s00383-018-4234-4
Thalidomide potentiates etoposide-induced apoptosis in murine neuroblastoma through suppression of NF-κB activation
Tomomasa Hiramatsu (2018)
10.1002/jcb.28037
Cyadox regulates the transcription of different genes by activation of the PI3K signaling pathway in porcine primary hepatocytes
Ju e Guo (2018)
10.1016/j.bbrc.2018.02.034
RIP2 enhances cell survival by activation of NF-ĸB in triple negative breast cancer cells.
R. Jaafar (2018)
10.1016/j.pharep.2018.01.002
Involvement of α-methylene-γ- and δ-lactones in the suppression of multidrug resistance in MCF-7 cells.
A. Długosz (2018)
10.3892/ol.2018.7936
Potential use of chymotrypsin-like proteasomal activity as a biomarker for prostate cancer.
X. Wei (2018)
10.1016/j.lfs.2018.06.035
Raddeanin A inhibits growth and induces apoptosis in human colorectal cancer through downregulating the Wnt/&bgr;‐catenin and NF‐&kgr;B signaling pathway
Y. Wang (2018)
10.1186/s13046-017-0607-0
The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway
S. He (2017)
10.1016/j.bioorg.2017.01.020
Synthesis of dual-action parthenolide prodrugs as potent anticancer agents.
A. Taleghani (2017)
10.1039/c6fo01588c
Garcinol sensitizes breast cancer cells to Taxol through the suppression of caspase-3/iPLA2 and NF-κB/Twist1 signaling pathways in a mouse 4T1 breast tumor model.
Shih-Hsin Tu (2017)
10.1038/cddis.2017.319
An autocrine inflammatory forward-feedback loop after chemotherapy withdrawal facilitates the repopulation of drug-resistant breast cancer cells
D. Jia (2017)
10.1016/B978-0-12-811020-1.00007-7
NO-H2S-Releasing Chimeras as a Multifaceted Approach to Cancer Therapy
K. Kashfi (2017)
10.1186/s12864-016-3308-8
A transcriptome-based model of central memory CD4 T cell death in HIV infection
Gustavo Olvera-García (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar